External Validation of the GREAT Score in Turkish Patients with Graves' Hyperthyroidism Treated with the Titration Regimen Method of Antithyroid Drugs: A Multicenter Study
dc.authorid | 0000-0002-0920-6895 | |
dc.authorid | 0000-0001-8084-848X | |
dc.authorid | 0000-0002-8329-140X | |
dc.authorscopusid | 36656843500 | |
dc.authorscopusid | 35271464000 | |
dc.authorscopusid | 11339331700 | |
dc.authorscopusid | 6602975843 | |
dc.authorscopusid | 57147304700 | |
dc.authorscopusid | 57208882907 | |
dc.authorscopusid | 55356053700 | |
dc.authorwosid | faruk, kilinc/W-7108-2018 | |
dc.authorwosid | Elbuken, Gulsah/ABD-5689-2020 | |
dc.authorwosid | Kadioglu, Pinar/AAM-9935-2020 | |
dc.authorwosid | Zuhur, Sayid/AAC-6839-2020 | |
dc.authorwosid | Sahin, Serdar/AAN-1047-2020 | |
dc.contributor.author | Zuhur, Sayid Shafi | |
dc.contributor.author | Elbüken, Gülşah | |
dc.contributor.author | Yıldız, İsmail | |
dc.contributor.author | Kadıoğlu, Pınar | |
dc.contributor.author | Erol, Selvinaz | |
dc.contributor.author | Şahin, Serdar | |
dc.contributor.author | Altuntaş, Yüksel | |
dc.date.accessioned | 2022-05-11T14:13:59Z | |
dc.date.available | 2022-05-11T14:13:59Z | |
dc.date.issued | 2019 | |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
dc.department | Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Biyoistatistik Ana Bilim Dalı | |
dc.description.abstract | Recently, the Graves & apos; Recurrent Events After Therapy score (GREAT) was proposed as a useful tool to predict relapse before starting antithyroid drugs (ATD) in patients with Graves & apos; disease (GD). Therefore, we intended to assess the validity of the GREAT score in Turkish patients with GD, including patients who experienced a poorly controlled disease (multiple episodes of hyperthyroidism followed by euthyroidism or rarely hypothyroidism) during ATD dose titration. This is a retrospective multicenter study including 517 patients with the first episode of GD who were treated for at least 12 months. The patients were classified as relapse+poorly controlled disease (non-remission) and remission groups. During a median follow-up time of 35 months (12-144 months), 191 (37%) patients experienced a relapse, 136 (26.3%) a poorly controlled disease, and 190 (36.7%) remained in remission. Patients with non-remission disease tended to have significantly higher serum levels of TRAb, fT4, and fT3, and have larger goiter sizes on palpation at baseline, as compared with the remission group. Non-remission disease occurred in 12, 35, and, 53% of the patients falling into GREAT class I, II, and III, respectively (hazard ratio 2.56, 95% CI 2.02-3.51, p=0.012, and hazard ratio 3.54, 95% CI 2.12-5.91, p<0.001, for GREAT class II and III against class I, respectively). According to our study, the GREAT score is a useful tool to predict the risk of relapse as well as the occurrence of poorly controlled disease before starting treatment with ATDs. | |
dc.identifier.doi | 10.1055/a-0974-3991 | |
dc.identifier.endpage | 633 | |
dc.identifier.issn | 0018-5043 | |
dc.identifier.issn | 1439-4286 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | 31499558 | |
dc.identifier.scopus | 2-s2.0-85072904372 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 627 | |
dc.identifier.uri | https://doi.org/10.1055/a-0974-3991 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/5732 | |
dc.identifier.volume | 51 | |
dc.identifier.wos | WOS:000488472400001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Zuhur, Sayid Shafi | |
dc.institutionauthor | Yıldız, İsmail | |
dc.institutionauthor | Elbüken, Gülşah | |
dc.institutionauthor | Topçu, Birol | |
dc.language.iso | en | |
dc.publisher | Georg Thieme Verlag Kg | |
dc.relation.ispartof | Hormone and Metabolic Research | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Graves' disease | |
dc.subject | relapse | |
dc.subject | antithyroid drugs | |
dc.subject | GREAT score | |
dc.subject | Predict Relapse | |
dc.subject | Disease | |
dc.subject | Therapy | |
dc.subject | Risk | |
dc.subject | Management | |
dc.subject | Recurrence | |
dc.subject | Remission | |
dc.title | External Validation of the GREAT Score in Turkish Patients with Graves' Hyperthyroidism Treated with the Titration Regimen Method of Antithyroid Drugs: A Multicenter Study | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 5734.pdf
- Boyut:
- 246.3 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text